Psychopharmacology Bulletin VOL 38 Supplement No. 1
-
Panel Discussion
-
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
-
Unmet Needs in the Treatment of Anxiety Disorders
By Mark H. Pollack, MD
-
Late-Life Anxiety Disorders
By Carl Salzman, MD
-
Understanding Psychiatric Disorders Through Functional Brain Imaging
By Clinton D. Kilts, PhD
-
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
-
Studying Non-Human Primates: A Gateway to Understanding Anxiety Disorders
By Ned H. Kalin, MD
-
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
By Charles B. Nemeroff, MD, PhD
